UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034812
Receipt number R000039615
Scientific Title Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder made from unripe orange fruits and green tea leaves(2)
Date of disclosure of the study information 2018/11/22
Last modified on 2019/03/14 15:44:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder made from unripe orange fruits and green tea leaves(2)

Acronym

Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder(2)

Scientific Title

Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder made from unripe orange fruits and green tea leaves(2)

Scientific Title:Acronym

Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder(2)

Region

Japan


Condition

Condition

sleeping disorder

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of ingention fermented tea leaf powder on the improvement of sleeping disorder.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

sleeping disorder

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

The subjects ingested the placebo meal for two weeks,and ingented the active meal for two weeks after two weeks.

Interventions/Control_2

The subjects ingested the active meal for two weeks,and ingented the active meal for two weeks after two weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1) Aged more than 20 (Healthy male and female between 20 and 70 years old)
2) Individuals who has subjective symptoms of sleeping disorder
3) Individuals who can refrain from over drinking and over eating during the test period
4) Individuals who understand the purpose and contents of the experiment

Key exclusion criteria

1)Subjects who are contracting or treating severe kidney and/or liver diseases
2)Individuals who have a chronic diseases and regularly use drugs
3)Those who can not stop taking a large amount of green tea or black tea during the test period
4)Pregnant women, or women with intending to become pregnant, and lactating woman
5)Individuals participating or intending to participate in a drug administration test
6)Individuals judged by the doctor to be unsuitable

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazunari Tanaka

Organization

Univercity of Nagasaki

Division name

Faculty of Nursing and Nutrition

Zip code


Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195

TEL

0958135216

Email

katanaka@sun.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hideki Ito

Organization

Univercity of Nagasaki

Division name

Regional Partnership Center

Zip code


Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195

TEL

0958135500

Homepage URL


Email

katanaka@sun.ac.jp


Sponsor or person

Institute

Univercity of Nagasaki

Institute

Department

Personal name



Funding Source

Organization

Bio-oriented Technology Research Advancement Institution,NARO

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 11 Month 17 Day

Date of IRB

2018 Year 10 Month 30 Day

Anticipated trial start date

2018 Year 11 Month 17 Day

Last follow-up date

2019 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 11 Month 08 Day

Last modified on

2019 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039615


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name